oregovomab: Clinical Trials

2 trials of oregovomab, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 terminated. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Active not recruiting 1, Terminated 1

Follow oregovomab: new trials by email Literature Review of oregovomab trials Research Report on oregovomab

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery
Oregovomab, Paclitaxel, Carboplatin - Carcinoma, Ovarian Epithelial, Ovarian Neoplasms
Phase 3Active not recruitingCanariaBio Inc.6152020-08-252026-04-01
Clinical Trial for Ovarian Cancer (OvaRex®)
oregovomab - Ovarian Cancer
Phase 3TerminatedUnither Pharmaceuticals3542002-12-012007-12-18

Conditions studied

Ovarian Neoplasms (2)  ·  Carcinoma, Ovarian Epithelial (1)  ·  Fallopian Tube Neoplasms (1)  ·  Peritoneal Neoplasms (1)

Sponsors

CanariaBio Inc. (1)  ·  Unither Pharmaceuticals (1)

Countries

United States (2)  ·  Argentina (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Canada (1)  ·  Chile (1)  ·  Czechia (1)  ·  Hungary (1)  ·  India (1)  ·  Italy (1)  ·  Mexico (1)  ·  South Korea (1)  ·  Spain (1)  ·  Taiwan (1)

Top investigators

Sunil Gupta, MD, FRCPC (1)